Mangalam Drugs & Organics Quarterly Results for Trading Insights
MANGALAM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-7 Cr
QSept 2025
Mangalam Drugs & Organics Quarterly Results Key Highlights
- Revenue of ₹49 Cr in Sept 2025 (-32.9% vs Mar 2025, -38.8% vs Sept 2024)
- Net Profit of ₹-7 Cr in Sept 2025 (-333.3% vs Sept 2024)
- EBITDA of ₹-3 Cr in Sept 2025 (-130.0% vs Mar 2025)
- Operating Margin of -6.0% in Sept 2025 (-20.0pp vs Mar 2025)
- Earnings Per Share of ₹-4.64 in Sept 2025 (-11700.0% vs Mar 2025)
Mangalam Drugs & Organics Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 49 | 73 | 57 | 80 | 102 | -32.9% | -38.8% |
| Net Profit (₹ Cr) | -7 | 0 | -14 | 3 | 4 | - | - |
| EBITDA (₹ Cr) | -3 | 10 | -5 | 9 | 12 | - | - |
| EPS (₹) | -4.64 | 0.04 | -8.72 | 1.70 | 2.23 | - | - |
| Operating Margin (%) | -6.0% | 14.0% | -8.0% | 11.0% | 11.0% | - | - |
Mangalam Drugs & Organics Share Price Trend Around Quarterly Results
Visualize Mangalam Drugs & Organics's 1-year price movement across quarterly results — ideal for logging trades in Mangalam Drugs & Organics share price
chart using Tickjournal. All values in ₹.
Related Pages for Mangalam Drugs & Organics
Additional stock information and data for MANGALAM
Revenue Trend (₹ Cr)
Sept 2024
80
Jun 2025
57
Mar 2025
73
Sept 2025
49
Net Profit Trend (₹ Cr)
Sept 2024
3
Jun 2025
-14
Mar 2025
0
Sept 2025
-7
Operating Margin Trend (%)
Sept 2024
11.0%
Jun 2025
-8.0%
Mar 2025
14.0%
Sept 2025
-6.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Mangalam Drugs & Organics quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores